
Theratechnologies THTX
Geschäftsbericht 2024
hinzugefügt 07.03.2026
Theratechnologies Anteile 2011-2026 | THTX
Anteile Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 77 M | 77 M | 76.9 M | 75.9 M | 73.5 M | 65.8 M | 63.2 M | 61 M | 61 M | 61 M | 60.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 77 M | 60.7 M | 68.5 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
299 M | $ 3.52 | -1.12 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
75 M | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
Aptorum Group Limited
APM
|
5.45 M | $ 0.8 | 1.27 % | $ 4.36 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
76.7 M | $ 4.18 | -0.48 % | $ 105 M | ||
|
argenx SE
ARGX
|
51.1 M | $ 715.26 | 1.7 % | $ 25 B | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
54.8 M | $ 230.51 | -0.22 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.39 | -6.09 % | $ 8.16 B | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
81.5 M | $ 6.12 | 1.16 % | $ 499 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
27.4 M | $ 6.62 | -0.15 % | $ 181 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | ||
|
BioCardia
BCDA
|
21.2 M | $ 1.36 | 7.09 % | $ 28.8 M | ||
|
Anika Therapeutics
ANIK
|
14.7 M | $ 14.64 | 1.92 % | $ 215 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
699 K | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
32.7 M | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
6.28 M | $ 2.65 | 0.38 % | $ 16.6 M | ||
|
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | ||
|
BioNTech SE
BNTX
|
244 M | $ 92.84 | 2.54 % | $ 27.2 B | ||
|
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.5 | -0.66 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
38.5 M | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
Burford Capital Limited
BUR
|
219 M | $ 8.28 | 2.73 % | $ 1.34 B | ||
|
AstraZeneca PLC
AZN
|
1.42 B | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
30.1 M | $ 1.15 | 3.6 % | $ 34.6 M |